Table 4—

Clinical and metabolic characteristics of the DPS subjects by sex

MenWomenP
n172350
Age (years)55.9 ± 7.154.8 ± 7.10.124
BMI (kg/m2)29.9 ± 3.631.9 ± 4.8<0.001
WHR0.99 ± 0.050.89 ± 0.06<0.001
Systolic blood pressure (mmHg)137 ± 17138 ± 180.412
Diastolic blood pressure (mmHg)87 ± 985 ± 100.045
FPG (mmol/l)6.3 ± 0.86.1 ± 0.70.010
2-h plasma glucose (mmol/l)8.8 ± 1.69.0 ± 1.40.146
Fasting serum insulin (mU/l)15.6 ± 8.514.4 ± 7.00.315
2-h serum insulin (mU/l)93.1 ± 60.996.3 ± 66.60.454
Total cholesterol (mmol/l)5.5 ± 0.95.7 ± 0.90.027
LDL cholesterol (mmol/l)3.6 ± 0,83.6 ± 0,80.464
HDL cholesterol (mmol/l)1.10 ± 0.281.26 ± 0.28<0.001
Triclycerides (mmol/l)1.8 ± 0.91.7 ± 0.70.419
MetS78.472.20.082
Obesity96.586.3<0.001
BMI >30 kg/m245.359.10.004
WHR >0.9 in men and >0.85 in women96.575.3<0.001
Hypertension62.960.90.647
Systolic blood pressure ≥140 mmHg38.244.00.181
Diastolic blood pressure ≥90 mmHg39.433.10.161
Use of antihypertensive medication29.129.20.745
Dyslipidemia51.248.60.599
HDL cholesterol: <0.9 in men and <1.0 mmol/l in women22.717.80.183
Triglycerides ≥1.7 mmol/l44.839.00.205
Use of lipid-lowering medication5.85.40.857
  • Obesity: BMI >30 kg/m2 or WHR >0.9 in men and >0.85 in women. Hypertension: systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg or use of oral antihypertensive medication. Dyslipidemia: triglycerides ≥1.7 mmol/l or HDL cholesterol <0.9 in men and <1.0 mmol/l in women or use of lipid-lowering medication.